Thrombolysis from P values to public health.
Brophy
J M
JM
Department of Cardiology, Centre Hospitalier de Verdun, Quebec.
D002170:Canada / Q000453:epidemiology; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D010960:Plasminogen Activators / Q000627:therapeutic use; D011634:Public Health; D016032:Randomized Controlled Trials as Topic; D013223:Statistics as Topic; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000379:methods*
D006493:Heparin; D013300:Streptokinase; D010960:Plasminogen Activators